Top Banner
Enteric Disease Management Within the Pipestone System Dr. Barry R. Kerkaert Pipestone, MN www.pipestonesystem. com Copyright 2010 – Pipestone Veterinary Clinic, Pipestone, Minnesota
50

Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Dec 20, 2014

Download

Business

John Blue

Applying Research to Decision Making to Maximize Returns at Pipestone - Dr. Barry R. Kerkaert, Director of Grow Finish Management, Pipestone Vet Clinic, from the 2012 Boehringer Ingelheim Swine Health Seminar, August 9-11, 2012, Wrightsville Beach, NC, USA.

More presentations at http://www.swinecast.com/2012-boehringer-ingelheim-carolina-swine-health-seminar
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Copyright 2010 – Pipestone Veterinary Clinic, Pipestone, Minnesota

Enteric Disease Management Within the Pipestone System

Dr. Barry R. KerkaertPipestone, MN

www.pipestonesystem.com

Page 2: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

History

• Pipestone Veterinary Clinic – 1942• Mixed animal practice

– 3 Veterinarians in 1994– 18 Veterinarians in 2012

• First managed farm in 1990• Today 46 managed sow farms

– 50% of those are filtered• Today manage 350,000 growing pigs

Page 3: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Our Brands:

Copyright 2010 – Pipestone Veterinary Clinic, Pipestone, Minnesota

Page 4: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Pipestone – Pipestone Pipestone Veterinary Clinics–home of the Pipestone System

RockNobles Jackson Martin Faribault

Blue EarthWatonwanCottonwoodMurray

LincolnLyonRedwood

Brown

Pipestone

Independence

Copyright 2010 – Pipestone Veterinary Clinic, Pipestone, Minnesota

Page 5: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

• Mission “Helping farmers today create the farms of

tomorrow”• Values

– Integrity– Caring– Commitment– Growth– Teamwork

Mission & Values

Copyright 2010 – Pipestone Veterinary Clinic, Pipestone, Minnesota

Page 6: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

The Change Imperative

“When the rate of external change exceeds the rate of internal change, the end of your business is in sight.”

Jack Welch, CEO General Electric

Page 7: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

USA Swine Industry Production Structure

• Traditional

– Family farms owned sows and land• 60 to 200 sows• Two farrowings per year• Manure applied to land• Seasonal labor

• 2012 – new

– Wide variety of ownership and size– Sow farms larger

• 1,000 to 5,000 sows breed to wean (for health reasons)• Wean 500 to 2,400 pigs per week

– Nursery Finisher or Wean to Finish • All in / All out

Page 8: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Evolution/Revolution to 3-Site Production

Page 9: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

50 Years of ImprovementSwine Efficiency 1959–2009• Hogs marketed increased 29%• Breeding herd decreased 39%• Over 2X carcass wt. produced/sow/per • Feed efficiency increased 33% / lb. carcass wt.• Water use reduced 41%/lb. carcass wt.• Total land use reduced 59%

78%/1000 lb. carcass wt.

• Carbon footprint reduced 35%/lb. carcass wt.

Source: Pork Checkoff

Page 10: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 11: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 12: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 13: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 14: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 15: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Genetic DAUGHTER GRAIN Source NUCLEUS PRODUCTION

(CHM) Stud F-1 gilt “Feed Production MILL”

SOW FARM

NURSERY WEAN & TO FINISHER FINISH

Slaughter Plant Further

processing FRESH PROCESSED

Retail store

Farmer owns

Management Contracts

Page 16: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Disease

• Respiratory

• Enteric

• Systemic (bacterial)– The suis’s

Page 17: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Disease

• Respiratory– PRRSv– SIV– Mycoplasma– Circovirus– Bacterial (the suis’s)

• Strep suis• Actinobacillus suis• H. parasuis

Page 18: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

PRRSv ($5 - $7 / pig)

• Objectives1. Produce and deliver negative pig

• Vaccinate if delivered to high risk area• Leave unvaccinated if in low risk area

2. Deliver a PRRSv positive vaccinated piglet• Utilize an PRRSv MLV vaccine

• Tools – Location– Prevention (filters)– Elimination

Page 19: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Mycoplasma / Circovirus ($2 to $7)

• Objective:– Sow farms + / - – Deliver pigs that are vaccinated and ready to grow

Page 20: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Swine Influenza

• Objective: – Deliver negative piglets

• Comments:– Very difficult to do consistently

Page 21: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

ISU VDL

Page 22: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Dr. Jeff Lubbe BIVI

Page 23: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Salmonella• Stress and contamination disease• Objective:

– Mitigate stresses on pigs causing the clinical disease

• Control – Vaccine for Salmonella Choleraesuis– Feed medication and or vaccination for Salmonella

Typhimurium

Page 24: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Jeff Luebbe BIVI

Page 25: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 26: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Our Enteric Philosophy

• Control of gut– Vaccine

• Ileitis• Salmonella• E-coli

– Medication• Stategically

Page 27: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Today’s Feed Cost (7-20-2012)

• Corn $7.81/bu• SBM $541.00/ton• DDGS $278/ton

$127 / hd!

Page 28: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Pipestone SGF Wean-Finish Feed Allocations & Medication Plan

Diet Wt Range

Budget #/Hd

Medication Cost Per Ton

Cost Per Pig

N1 Pellet 12-15 2.0 Mecadox(25g/ton)/Terramycin(400g/ton) $18.68 $.02

SB NPII 15-20 6.0 Mecadox(25g/ton)/Terramycin(400g/ton) $18.68 $.06 SB NPII-B 20-27 6.0 Mecadox(25g/ton)/Terramycin(400g/ton) $18.68 $.06

SB N4 27-40 24

No Medication- Water Vaccinate - -

SB N5 40-51 19 No Medication- Water Vaccinate - -

SB GF1 51-76.4 49 Denagard (35g/ton) $15.96 $.39

SB GF2 76.4-95.9 42 Stafac 20 (10g/ton) $1.65 $.03

SB GF3 95.9-136.3 96 Stafac 20 (10g/ton) $1.65 $.08

SB GF4 136.3-177 109 Stafac 20 (10g/ton) $1.65 $.09

SB GF5 177-206 90 Stafac 20 (10g/ton) $1.65 $.07

SB GF6 206-231 78 Stafac 20 (10g/ton) $1.65 $.06 SB GF7 231-275 140 Non Medicated – Paylean (4.5 g/ton) - -

SB GF8 Step-Up 100 Non Medicated – Paylean (6.75 g/ton) TOTAL $.86

Page 29: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 30: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Research and Information historically

• Information– PigCHAMP– Grow – Finish

• Spread sheets or custom

• Research– On farm trials

• Has limitations

– Relationship with Universities• Vendor research

Page 31: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Pipestone Research Committee (2009)

• Director – Dr. Scott Dee• Members

– Dr. Joel Nerem– Dr. Spencer Wayne– Dr. Cameron Schmitt– Dr. Barry Kerkaert– Dr. Luke Minion– Dan Hanson

Page 32: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Research and information today

• Timely

• Precision

• Complexity

• Partners

• Collaboration

Page 33: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Perspective on research

• New products – Supported by data

• Avoid internal bias from experience• Limitations

– Research vs. commercial out come (70%)– Information from other systems / sources

• Value– Creation– Intellectual property

Page 34: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Research investment

Page 35: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Perspective on Partners

• Innovative

• Collaboration

• Value

• Joint mission to improve

• Not feed

Page 36: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Areas of interest

• Animal health

– PRRSv

– Ileitis

– Mycoplasma

– Circovirus

Page 37: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Areas of interest

• Bio – security measures

• Air filtration

• Manure

Page 38: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Areas of interest

• Genetics

• Animal welfare

• Meat quality

• Energy / Feed presentation

Page 39: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Most recent trial

• Ileitis vaccine trial

Page 40: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Comparative efficacy of Enterisol ® Ileitis versus Tylan® feed grade.

Page 41: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Trial Objective

• To determine if Enterisol® Ileitis vaccine performs better than Tylan® feed grade in a step down program as a way to control the effects of a Lawsonia intracellularis infection.

• A pen level study with the primary parameter being feed efficiency (FE)

Page 42: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Materials and Methods

•Trial conducted at Pipestone Vet Clinic research barn from 6-28 to 12-19, 2011• 2080 weaned pigs from 2 sister sow farms in the Pipestone system.•Pigs weighed and allocated to two treatment groups

Trt Trt Name Treatment Group Description

1

Enterisol

Ileitis/Stafac

40 pens of 26 pigs vaccinated with Enterisol Ileitis at day 0

and fed 10 grams Stafac per ton starting on day 40 until day

120.

2 Tylan

40 pens of 26 pigs fed 100 grams of Tylan per ton from day

40 to day 58, followed by feeding 40 grams of Tylan per ton

until day 120.

Page 43: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Materials and Methods

• 2-3 pigs per pen (10% of population) were inoculated with Lawsonia intracellularis gut homogenate at log 4.5 x 109

Page 44: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Performance Results

Response variable Enterisol Ileitis Tylan P-value1

d40-market feed to gain, lbs 2.97 3.05 0.13

d-7-126 feed to gain, lbs 2.38a

2.43b

0.05d-7-market feed to gain, lbs 2.62 2.70 0.06

0.08 / 2.70 X $127 = $3.76

Table 2. Least square means for performance data by main effect (treatment).

Vaccine Treatment

1ANOVA P-value.

ab Means with different superscripts indicate difference at P≤0.05 (Student's t).

Page 45: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Vaccine, Feed meds, and Treatment Costs

Table 8. Least square means for treatment cost by main effect (treatment).

Vaccine Treatment

Response variablei Enterisol Ileitis Tylan P-value1

Medication program cost per pig, ($)2 1.29a 1.54b <.0001

d-7-market injectable/water med cost per pig, ($)3 0.96 0.98 0.18

Page 46: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Conclusions• A Lawsonia intracellularis seeder challenge model is possible in a

large scale commercial study.

• Pigs on the Enterisol Ileitis/Stafac program had a 2.9% improvement in FE (P<0.05)

• Total return on investment favored the Enterisol Ileitis/Stafac group by $3.05.

• Today • $0.25 + $3.76 = $4.01 (vaccine and Stafac)

ksaddori
Looks possible but that more work needs to be done to fine tune it before I would consider doing it at a customers again.
ksaddori
There will likely be an agruement that everything after the denegard trt is meaningless and they would have a strong leg to stand on.
Page 47: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

“Change is: often desirable, frequently necessary, always inevitable.”

Page 48: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone
Page 49: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

Our hobbies. . . . . . . .

Page 50: Dr. Barry Kerkaert - Applying Research to Decision Making to Maximize Returns at Pipestone

THANK YOU